7.01
price down icon0.14%   -0.010
 
loading
Schlusskurs vom Vortag:
$7.02
Offen:
$7.05
24-Stunden-Volumen:
64,196
Relative Volume:
0.90
Marktkapitalisierung:
$146.73M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.72M
KGV:
-2.477
EPS:
-2.83
Netto-Cashflow:
$-7.41M
1W Leistung:
-5.27%
1M Leistung:
-28.47%
6M Leistung:
+60.23%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$6.7954
$7.32
1-Wochen-Bereich:
Value
$6.7954
$7.80
52-Wochen-Spanne:
Value
$3.75
$11.54

Alpha Cognition Inc Stock (ACOG) Company Profile

Name
Firmenname
Alpha Cognition Inc
Name
Telefon
(858) 344-4375
Name
Adresse
1200-750 W PENDER ST, VANCOUVER
Name
Mitarbeiter
57
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ACOG's Discussions on Twitter

Vergleichen Sie ACOG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ACOG
Alpha Cognition Inc
7.01 146.73M 0 -14.72M -7.41M -2.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.60 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
472.79 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.45 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
801.26 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
331.07 35.16B 4.56B -176.77M 225.30M -1.7177

Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-18 Eingeleitet H.C. Wainwright Buy

Alpha Cognition Inc Aktie (ACOG) Neueste Nachrichten

pulisher
10:33 AM

Can technical indicators confirm Alpha Cognition Inc.’s reversal - newser.com

10:33 AM
pulisher
10:28 AM

How high can Alpha Cognition Inc. stock goWeekly Gains Report & Weekly Return Optimization Alerts - newser.com

10:28 AM
pulisher
05:38 AM

Real time pattern detection on Alpha Cognition Inc. stock2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com

05:38 AM
pulisher
Oct 10, 2025

Risk adjusted return profile for Alpha Cognition Inc. analyzedWeekly Profit Summary & AI Powered Trade Plan Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Alpha Cognition Inc. outperform the marketTrade Risk Report & Community Verified Swing Trade Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Statistical indicators supporting Alpha Cognition Inc.’s strengthTrade Entry Report & Risk Managed Investment Strategies - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Strategies to average down on Alpha Cognition Inc.July 2025 Trends & Risk Managed Investment Signals - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Opaleye Management Inc. Acquires Significant Stake in Alpha Cognition Inc. - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Will Alpha Cognition Inc. stock outperform Nasdaq indexMarket Volume Summary & Real-Time Buy Zone Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How to escape a deep drawdown in Alpha Cognition Inc.Trade Risk Report & Free Long-Term Investment Growth Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Multi asset correlation models including Alpha Cognition Inc.July 2025 Analyst Calls & AI Based Buy and Sell Signals - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Is Alpha Cognition Inc a good long term investmentRSI Overbought/Oversold & We Spotted the Next Tesla – See Inside - earlytimes.in

Oct 08, 2025
pulisher
Oct 06, 2025

Alpha Cognition to Present Clinical Data at ASCP Annual Meeting - Business Wire

Oct 06, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 06:09:34 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Alpha Cognition Inc. stock a safe buy before earningsTake Profit & Daily Profit Focused Stock Screening - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Alpha Cognition Inc. (NASDAQ:ACOG) Sees Significant Decrease in Short Interest - Defense World

Oct 05, 2025
pulisher
Oct 03, 2025

Alpha Cognition Secures $35 Million in Oversubscribed Public Offering to Accelerate Neurodegenerative Disease Treatment Commercialization - citybuzz

Oct 03, 2025
pulisher
Oct 02, 2025

Alpha Cognition prices $35M public offering of common shares - msn.com

Oct 02, 2025
pulisher
Oct 01, 2025

Detecting support and resistance levels for Alpha Cognition Inc.Quarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Alpha Cognition Inc. Announces Proposed Public Offering of Common Shares - BioSpace

Oct 01, 2025
pulisher
Oct 01, 2025

Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares - BioSpace

Oct 01, 2025
pulisher
Oct 01, 2025

Alpha Cognition raises $35 million in oversubscribed public offering By Investing.com - Investing.com Australia

Oct 01, 2025
pulisher
Sep 30, 2025

Alpha Cognition announces proposed public offering of shares By Investing.com - Investing.com Nigeria

Sep 30, 2025
pulisher
Sep 30, 2025

Alpha Cognition raises $35 million in oversubscribed public offering - Investing.com

Sep 30, 2025
pulisher
Sep 30, 2025

Alpha Cognition Inc announces pricing of oversubscribed underwritten public offering of 5.6 mln common shares at $6.25 per share - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

$35M Oversubscribed Offering: Alpha Cognition Accelerates ZUNVEYL Alzheimer's Drug Commercial Launch - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

Alpha Cognition announces proposed public offering of shares - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

Alpha Cognition stock falls after announcing public offering plan By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

Alpha Cognition stock falls after announcing public offering plan - Investing.com

Sep 30, 2025

Finanzdaten der Alpha Cognition Inc-Aktie (ACOG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Alpha Cognition Inc-Aktie (ACOG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
MERTZ PHILLIP JOSEPH
Director
Aug 18 '25
Sale
9.00
27,778
250,002
22,462
MERTZ LEONARD POWELL
Director
Aug 18 '25
Buy
9.00
27,778
250,002
121,503
McFadden Michael E.
Chief Executive Officer
Nov 13 '24
Buy
5.75
2,608
14,996
14,142
MERTZ LEONARD POWELL
Director
Nov 13 '24
Buy
5.75
8,695
49,996
93,725
HAVENS JOHN PRENTISS
Director
Nov 13 '24
Buy
5.75
4,347
24,995
273,272
$84.81
price up icon 1.12%
$22.99
price up icon 7.56%
$32.66
price up icon 2.62%
$102.75
price up icon 0.67%
$164.51
price up icon 1.41%
biotechnology ONC
$331.45
price up icon 3.42%
Kapitalisierung:     |  Volumen (24h):